SCHEMBL21936271

SCHEMBL21936271

C=Cc1cc(C=N)c(NCC(C)(C)O)cc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21872491 0.83 IL1B (0.34) —
SCHEMBL21936262 0.81 — —
SCHEMBL21937318 0.77 — —
SCHEMBL21936720 0.76 — —
SCHEMBL21872420 0.71 — —
SCHEMBL21872441 0.70 AR (0.37) —
SCHEMBL24900934 0.69 — —
SCHEMBL21872806 0.69 — —
SCHEMBL27004923 0.68 IDH2 (0.31) —
SCHEMBL24874016 0.68 TTR (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3633380-A1 METHOD FOR PREDICTING THERAPEUTIC EFFECT OF LSD1 INHIBITOR BASED ON EXPRESSION OF INSM1 Taiho Pharmaceutical Co., Ltd. (JP) 2020-04-08 — — EP disclosed
Send feedback